These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12065193)

  • 1. Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan.
    Zuideveld KP; van Gestel A; Peletier LA; Van der Graaf PH; Danhof M
    Eur J Pharmacol; 2002 Jun; 445(1-2):43-54. PubMed ID: 12065193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flesinoxan treatment reduces 5-HT1A receptor mRNA in the dentate gyrus independently of high plasma corticosterone levels.
    Sibug RM; Compaan JC; Meijer OC; Van der Gugten J; Olivier B; De Kloet ER
    Eur J Pharmacol; 1998 Jul; 353(2-3):207-14. PubMed ID: 9726650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus.
    Compaan JC; Groenink L; van der Gugten J; Maes RA; Olivier B
    Eur J Neurosci; 1996 Nov; 8(11):2340-7. PubMed ID: 8950098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal.
    Bouwknecht JA; van der Gugten J; Hijzen TH; Maes RA; Hen R; Olivier B
    Psychopharmacology (Berl); 2001 Feb; 153(4):484-90. PubMed ID: 11243496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635.
    Cryan JF; Kelliher P; Kelly JP; Leonard BE
    J Psychopharmacol; 1999; 13(3):278-83. PubMed ID: 10512084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus.
    Compaan JC; Groenink L; Van der Gugten J; Maes RA; Olivier B
    Eur J Pharmacol; 1997 Apr; 324(2-3):161-8. PubMed ID: 9145767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects.
    Groenink L; Van der Gugten J; Verdouw PM; Maes RA; Olivier B
    Eur J Pharmacol; 1995 Jul; 280(2):185-93. PubMed ID: 7589185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge.
    Groenink L; Van der Gugten J; Compaan JC; Maes RA; Olivier B
    Psychopharmacology (Berl); 1997 May; 131(1):93-100. PubMed ID: 9181641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor.
    Groenink L; Van der Gugten J; Mos J; Maes RA; Olivier B
    Eur J Pharmacol; 1995 Jan; 272(2-3):177-83. PubMed ID: 7713161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLX-112, a highly selective 5-HT
    Newman-Tancredi A; Depoortère R; Carilla-Durand E; Tarayre JP; Kleven M; Koek W; Bardin L; Varney MA
    Pharmacol Biochem Behav; 2018 Feb; 165():56-62. PubMed ID: 29126856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice.
    McAllister-Williams RH; Anderson AJ; Young AH
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):1-8. PubMed ID: 11343623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a 5-HT(1A) receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats.
    Suwabe A; Kubota M; Niwa M; Kobayashi K; Kanba S
    Brain Res; 2000 Mar; 858(2):393-401. PubMed ID: 10708692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers.
    Pitchot W; Wauthy J; Hansenne M; Pinto E; Fuchs S; Reggers J; Legros JJ; Ansseau M
    Psychopharmacology (Berl); 2002 Oct; 164(1):27-32. PubMed ID: 12373416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
    Zuideveld KP; Treijtel N; Maas HJ; Gubbens-Stibbe JM; Peletier LA; van Der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Jan; 300(1):330-8. PubMed ID: 11752133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice.
    Groenink L; van der Gugten J; Zethof TJ; van der Heyden JA; Olivier B
    Pharmacol Biochem Behav; 1996 May; 54(1):249-54. PubMed ID: 8728565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
    Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.